CLEVELAND: A team from Cleveland Clinic has developed a new model for prioritizing patients waiting for a lung transplant, aimed at improving outcomes and reducing deaths among those in need of donor lungs. The new method offers an improved strategy for organ allocation by taking into account how the time a patient has spent on the waiting list could impact the severity of their disease and the urgency of their need for a transplant.
The results of a study looking at this new method were published today in The American Journal of Respiratory and Critical Care Medicine.
Currently, lung transplant candidates are ranked by a scoring equation called the Composite Allocation Score (CAS). Candidates are assigned a number based on factors including how stable they are while waiting, chances of survival after receiving a new organ, and how easily they can be matched for available organs. Those with the highest scores are given priority and offered donor lungs first. However, the scores are based on tests given twice a year at transplant centers. That means that unless a patient’s health suddenly and drastically changes, their score will remain the same for at least six months.
“The problem with this method is that the scoring equations fail to consider how a patient’s health status changes as they spend more time on the list,” said Maryam Valapour, M.D., M.P.P., director of Lung Transplant Outcomes at Cleveland Clinic. “The longer a patient lives with a severe lung disease, the more their risk of developing severe complications increases. This is something clinicians observe every day – that our patients’ risk of developing complications changes over time. Therefore, some patients’ scores may not reflect how urgently they need a transplant.”
To determine how the amount of time on the waitlist affects clinical outcomes, the team of researchers analyzed data from 12,000 American adults listed for lung transplant between 2015 to 2020. The study showed that for many patients, their risk of death prior to transplant increased as they spent longer times waiting for donor lungs.
When the team looked at patients who died on the waiting list, they found that many had not been given enough priority in the CAS. To more accurately score the candidates, the team developed a more dynamic method called the multistate composite model that accounted for the type of lung disease and time on the waiting list. When they recalculated the original scores with their new equation, it consistently marked those patients as high priority. However, for patients who originally received low-priority scores and remained stable over time, using the new method did not change their scores.
“The approaches we present in our paper are capable of identifying whose trajectory is more stable on the waiting list versus those whose trajectory is worsening between six-month clinical updates. The estimates in our model more closely align with observed trends in individual U.S. lung transplant patients,” says Jarrod Dalton, Ph.D., director of Lerner Research Institute’s Center for Populations and Health Research, who is first author of the paper. “This approach may allow us to more accurately prioritize time-sensitive lung transplant candidates and decrease waitlist mortality for patients with end-stage lung disease.”
This study was done with the support of the National Institutes of Health.
“This research advances us towards development of a more comprehensive prediction model for risk of mortality among lung transplant candidates that could help guide decisions about patients who are in greater need for lung transplant and increase their odds for survival,” said James P. Kiley, Ph.D., director of the Division of Lung Diseases at the National Heart, Lung, and Blood Institute (NHLBI).
In 2022, there were over 3,000 candidates added to the lung transplant waitlist with over 2,600 lung transplants performed, according to UNOS. While the numbers of donors and transplants are improving, there is still a shortage of available organs in the United States.
Research reported in this publication was supported by the National Institutes of Health under Award Number R01HL153175. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 77,000 employees worldwide are more than 5,658 salaried physicians and researchers, and 19,000 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,699-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, more than 275 outpatient facilities, including locations in northeast Ohio; southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2022, there were 12.8 million outpatient encounters, 303,000 hospital admissions and observations, and 270,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
###
